ClinicalTrials.gov record
Recruiting Phase 2 Interventional

A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease

ClinicalTrials.gov ID: NCT07094516

Public ClinicalTrials.gov record NCT07094516. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 24, 2026, 12:10 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Placebo-controlled, Parallel Group, 72-week Study to Evaluate the Efficacy and Safety of VHB937 in Participants With Early Alzheimer's Disease Followed by an Extension

Study identification

NCT ID
NCT07094516
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
407 participants

Conditions and interventions

Interventions

  • Placebo Other
  • VHB937 Biological

Other · Biological

Eligibility (public fields only)

Age range
50 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 6, 2025
Primary completion
Sep 13, 2028
Completion
Dec 30, 2030
Last update posted
Mar 22, 2026

2025 – 2030

United States locations

U.S. sites
20
U.S. states
13
U.S. cities
20
Facility City State ZIP Site status
Banner Alzheimers Institute Phoenix Arizona 85006 Recruiting
University of California San Diego La Jolla California 92037 Recruiting
University of California at Los Angeles Los Angeles California 90095 Recruiting
Jem Research Institute Atlantis Florida 33462-6608 Recruiting
Visionary Investigators Network Aventura Florida 33180 Recruiting
K2 Medical Research LLC Maitland Florida 32751 Recruiting
Renstar Medical Research Ocala Florida 34471 Recruiting
Charter Research The Villages The Villages Florida 32162 Recruiting
Alzheimers Research Treatment Ctr Wellington Florida 33414 Recruiting
Conquest Research Winter Park Florida 32789 Recruiting
Hawaii Pacific Neuroscience LLC Honolulu Hawaii 96817 Recruiting
University of Kansas Hospital Fairway Kansas 66205 Recruiting
ActivMed Practices and Research Methuen Massachusetts 01844 Recruiting
Citizens Memorial Hospital Neurology CLinic Bolivar Missouri 65613 Recruiting
UNC Hosp Invest Drug Serv Pharm Chapel Hill North Carolina 27514 Recruiting
The Ohio State University Columbus Ohio 43210 Recruiting
Neural Net Research Portland Oregon 97225 Recruiting
Abington Neurological Associates Ltd Willow Grove Pennsylvania 19090 Recruiting
University of Texas Health Science Center at San Antonio San Antonio Texas 78229-3900 Recruiting
University of Washington Medical Center Seattle Washington 98195 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 30 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07094516, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 22, 2026 · Synced Apr 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07094516 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →